← All organizations

Hangzhou Grand Biologic Pharmaceutical, Inc.

Government

Also known as: Hangzhou Grand Biologic Pharmaceutical, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Mar 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (11 distinct, 4 trials)

Phase 4 (10 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

rasburicase

Recent trials (4)

NCT06250400Lead sponsorPhase 4Mar 31, 2024
NCT04982380CollaboratorPhase 4Jul 31, 2021
NCT04765995Lead sponsorPhase 1Mar 1, 2021
NCT04034641Lead sponsorPhase 4Nov 1, 2019

Details

Last known activity: Mar 31, 2024